Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
37
RNLSY Quote, Financials, Valuation and Earnings
Last price:
$7.70
Seasonality move
:
-4.66%
Day range:
$7.76 - $7.87
52-week range:
$7.76 - $11.20
Dividend yield:
6.21%
P/E ratio:
16.57x
P/S ratio:
0.18x
P/B ratio:
0.36x
Volume:
67.5K
Avg. volume:
45.5K
1-year change:
-27.69%
Market cap:
$11.4B
Revenue:
$60.9B
EPS (TTM):
$0.61
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $49.6B | $49.3B | $48.9B | $56.7B | $60.9B | |
| Revenue Growth (YoY) | -20.15% | -0.72% | -0.88% | 16.06% | 7.34% | |
| Cost of Revenues | $41.4B | $39.9B | $39.1B | $44.8B | $48.2B | |
| Gross Profit | $8.2B | $9.4B | $9.7B | $11.9B | $12.7B | |
| Gross Profit Margin | 16.6% | 19.06% | 19.9% | 20.93% | 20.86% | |
| R&D Expenses | $2.9B | $2.7B | $2.2B | $2.3B | $2.5B | |
| Selling, General & Admin | $5.7B | $5.3B | $4.8B | $5.1B | $5.6B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $8.9B | $8.2B | $6.9B | $7.6B | $8.3B | |
| Operating Income | -$628.1M | $1.2B | $2.8B | $4.3B | $4.4B | |
| Net Interest Expenses | $569.9M | $326.6M | $284.7M | $155.9M | $180.8M | |
| EBT. Incl. Unusual Items | -$8.7B | $1.3B | $2.2B | $3.1B | $1.7B | |
| Earnings of Discontinued Ops. | -- | $494.6M | -$2.4B | -- | -- | |
| Income Tax Expense | $479.7M | $675.6M | $552.6M | $566.2M | $700.3M | |
| Net Income to Company | -$9.2B | $649.6M | $1.7B | $2.5B | $964.4M | |
| Minority Interest in Earnings | $43.4M | -$93.5M | $381.8M | -$126.7M | -$150.4M | |
| Net Income to Common Excl Extra Items | -$9.1B | $1.1B | -$373.3M | $2.4B | $813.9M | |
| Basic EPS (Cont. Ops) | -$6.74 | $0.77 | -$0.27 | $1.76 | $0.60 | |
| Diluted EPS (Cont. Ops) | -$6.74 | $0.77 | -$0.27 | $1.73 | $0.59 | |
| Weighted Average Basic Share | $1.4B | $1.4B | $1.4B | $1.4B | $1.4B | |
| Weighted Average Diluted Share | $1.4B | $1.4B | $1.4B | $1.4B | $1.4B | |
| EBITDA | -$2.9B | $6.3B | $6.4B | $6.9B | $5.5B | |
| EBIT | -$8.3B | $1.7B | $2.6B | $3.5B | $2.1B | |
| Revenue (Reported) | $49.6B | $49.3B | $48.9B | $56.7B | $60.9B | |
| Operating Income (Reported) | -$628.1M | $1.2B | $2.8B | $4.3B | $4.4B | |
| Operating Income (Adjusted) | -$8.3B | $1.7B | $2.6B | $3.5B | $2.1B | |
| Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $50.2B | $48.9B | $48.3B | $56.8B | $60.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $41.8B | $39.6B | $38.7B | $44.9B | $47.7B | |
| Gross Profit | $8.4B | $9.3B | $9.6B | $11.9B | $12.6B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $2.9B | $2.7B | $2.2B | $2.3B | $2.4B | |
| Selling, General & Admin | $5.7B | $5.2B | $4.7B | $5.1B | $5.6B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $8.9B | $8.2B | $6.9B | $7.6B | $8.2B | |
| Operating Income | -$542.7M | $1.2B | $2.7B | $4.3B | $4.4B | |
| Net Interest Expenses | $575.1M | $323.3M | $282.1M | $156M | $178.9M | |
| EBT. Incl. Unusual Items | -$8.4B | $1.3B | $2.2B | $3.1B | $1.7B | |
| Earnings of Discontinued Ops. | -- | $488.5M | -$2.5B | -- | -- | |
| Income Tax Expense | $475.9M | $664.4M | $546.6M | $567M | $693.2M | |
| Net Income to Company | -$8.9B | $640.1M | $1.7B | $2.5B | $964.7M | |
| Minority Interest in Earnings | $36.8M | -$91.2M | $383.3M | -$126.4M | -$149.1M | |
| Net Income to Common Excl Extra Items | -$8.9B | $1B | -$420.3M | $2.4B | $815.6M | |
| Basic EPS (Cont. Ops) | -$6.55 | $0.76 | -$0.31 | $1.77 | $0.60 | |
| Diluted EPS (Cont. Ops) | -$6.55 | $0.76 | -$0.31 | $1.74 | $0.58 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$2.6B | $6.3B | $6.3B | $6.9B | $5.5B | |
| EBIT | -$8B | $1.7B | $2.6B | $3.5B | $2.1B | |
| Revenue (Reported) | $50.2B | $48.9B | $48.3B | $56.8B | $60.2B | |
| Operating Income (Reported) | -$542.7M | $1.2B | $2.7B | $4.3B | $4.4B | |
| Operating Income (Adjusted) | -$8B | $1.7B | $2.6B | $3.5B | $2.1B | |
| Period Ending | 2022-07-18 | 2023-07-18 | 2024-07-18 | 2025-07-18 | 2026-07-18 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $25.9B | $24.8B | $22.1B | $21.9B | $22.4B | |
| Short Term Investments | $524M | $1B | $629.5M | $552.7M | $554.6M | |
| Accounts Receivable, Net | $51.3B | $45.6B | $48.5B | $55.8B | $57.6B | |
| Inventory | $6.9B | $5.4B | $5.6B | $5.4B | $5.7B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $91.4B | $81.9B | $87.7B | $95.4B | $94.1B | |
| Property Plant And Equipment | $21.1B | $18.3B | $12.6B | $13.5B | $14.4B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $1.1B | $1.2B | $292.8M | $289.6M | $506.8M | |
| Other Intangibles | $6.7B | $6.1B | $4.7B | $4.8B | $4.9B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $142.4B | $128.8B | $126.9B | $134.8B | $134.6B | |
| Accounts Payable | $10.2B | $9B | $9B | $8.8B | $10.2B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $146.4M | $140.4M | $114.7M | $103.9M | $107.2M | |
| Other Current Liabilities | $6.7B | $5B | $5.2B | $6.3B | $6.4B | |
| Total Current Liabilities | $87.7B | $76.2B | $78.3B | $86.1B | $90.1B | |
| Long-Term Debt | $15.2B | $13.8B | $10.6B | $8.8B | $6.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $111.2B | $97.2B | $95B | $100.9B | $102.3B | |
| Common Stock | $1.4B | $1.3B | $1.2B | $1.2B | $1.2B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $30.5B | $30.9B | $31B | $32.9B | $31.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $696.2M | $649.9M | $794.6M | $975M | $825.2M | |
| Total Equity | $31.2B | $31.6B | $31.8B | $33.9B | $32.4B | |
| Total Liabilities and Equity | $142.4B | $128.8B | $126.9B | $134.8B | $134.6B | |
| Cash and Short Terms | $26.4B | $25.8B | $22.7B | $22.4B | $23B | |
| Total Debt | $77.3B | $68.3B | $66.7B | $71.3B | $72.5B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $25.9B | $24.8B | $22.1B | $21.9B | $22.4B | |
| Short Term Investments | $524M | $1B | $629.5M | $552.7M | $554.6M | |
| Accounts Receivable, Net | $51.3B | $45.6B | $48.5B | $55.8B | $57.6B | |
| Inventory | $6.9B | $5.4B | $5.6B | $5.4B | $5.7B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $91.4B | $81.9B | $87.7B | $95.4B | $94.1B | |
| Property Plant And Equipment | $21.1B | $18.3B | $12.6B | $13.5B | $14.4B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $1.1B | $1.2B | $292.8M | $289.6M | $506.8M | |
| Other Intangibles | $6.7B | $6.1B | $4.7B | $4.8B | $4.9B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $142.4B | $128.8B | $126.9B | $134.8B | $134.6B | |
| Accounts Payable | $10.2B | $9B | $9B | $8.8B | $10.2B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $146.4M | $140.4M | $114.7M | $103.9M | $107.2M | |
| Other Current Liabilities | $6.7B | $5B | $5.2B | $6.3B | $6.4B | |
| Total Current Liabilities | $87.7B | $76.2B | $78.3B | $86.1B | $90.1B | |
| Long-Term Debt | $15.2B | $13.8B | $10.6B | $8.8B | $6.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $111.2B | $97.2B | $95B | $100.9B | $102.3B | |
| Common Stock | $1.4B | $1.3B | $1.2B | $1.2B | $1.2B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $696.2M | $649.9M | $794.6M | $975M | $825.2M | |
| Total Equity | $31.2B | $31.6B | $31.8B | $33.9B | $32.4B | |
| Total Liabilities and Equity | $142.4B | $128.8B | $126.9B | $134.8B | $134.6B | |
| Cash and Short Terms | $26.4B | $25.8B | $22.7B | $22.4B | $23B | |
| Total Debt | $77.3B | $68.3B | $66.7B | $71.3B | $72.5B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$9.2B | $649.6M | $1.7B | $2.5B | $964.4M | |
| Depreciation & Amoritzation | $5.4B | $4.6B | $3.7B | $3.5B | $3.4B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $386M | $147.9M | -$298.5M | $76.9M | $236M | |
| Change in Inventories | -$127.9M | $1.1B | -$1.4B | $288M | -$755.5M | |
| Cash From Operations | $6.6B | $2.9B | $3.8B | $4.8B | $7.8B | |
| Capital Expenditures | $4.6B | $2.9B | $2.8B | $3.3B | $3.2B | |
| Cash Acquisitions | -- | -$121.9M | -$40.1M | $23.8M | -$305.2M | |
| Cash From Investing | -$4.8B | -$1.9B | -$3.5B | -$2.4B | -$2.2B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$79M | -$580.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.1B | $2.6B | $2.2B | -- | -- | |
| Long-Term Debt Repaid | -$673.8M | -$980.9M | -$253.1M | -$1.3B | -$1.7B | |
| Repurchase of Common Stock | -$50.2M | -$42.6M | -$63.3M | -$189.5M | -- | |
| Other Financing Activities | $6B | -$2.3B | -$2.3B | -$1.6B | -$920M | |
| Cash From Financing | $6.4B | -$746.6M | -$504.1M | -$3.2B | -$3.5B | |
| Beginning Cash (CF) | $17.1B | $25.7B | $23.1B | $23.6B | $22.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $8.1B | $191.7M | -$167.7M | -$813M | $2B | |
| Ending Cash (CF) | $24.8B | $25.9B | $23B | $22.4B | $24.4B | |
| Levered Free Cash Flow | $2B | -$65.1M | $979.7M | $1.5B | $4.5B | |
| Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$8.9B | $640.1M | $1.7B | $2.5B | $964.7M | |
| Depreciation & Amoritzation | $5.4B | $4.6B | $3.7B | $3.5B | $3.4B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $416.1M | $141.7M | -$296.2M | $73M | $234.1M | |
| Change in Inventories | -$54.2M | $1.1B | -$1.4B | $280.2M | -$754.9M | |
| Cash From Operations | $6.9B | $2.7B | $3.7B | $4.8B | $7.7B | |
| Capital Expenditures | $4.6B | $2.9B | $2.8B | $3.3B | $3.2B | |
| Cash Acquisitions | -- | -$117.8M | -$38.9M | $23.7M | -$302.3M | |
| Cash From Investing | -$4.8B | -$1.9B | -$3.5B | -$2.4B | -$2.2B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$79.6M | -$577.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.2B | $2.6B | $2.1B | -- | -- | |
| Long-Term Debt Repaid | -$697.7M | -$978.8M | -- | -$1.3B | -$1.7B | |
| Repurchase of Common Stock | -$48.7M | -$43.4M | -$62.8M | -$190.3M | -- | |
| Other Financing Activities | $6B | -$2.2B | -$2.3B | -$1.6B | -$904.5M | |
| Cash From Financing | $6.5B | -$741.4M | -$546.7M | -$3.2B | -$3.5B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $8.4B | $59.9M | -$530.2M | -$1.3B | $2B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2.3B | -$166.4M | $919.6M | $1.5B | $4.5B | |
| Period Ending | 2022-07-18 | 2023-07-18 | 2024-07-18 | 2025-07-18 | 2026-07-18 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get RNLSY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RNLSY
Sector
P/E ratio
16.57x
16.92x
PEG ratio
0.04x
0.17x
P/B ratio
0.36x
1.42x
Price / LTM sales
0.18x
0.68x
Growth Metrics
RNLSY
Sector
Revenue growth
--
0.64%
Earnings growth
--
-1.02%
Revenue (5-year growth)
-0.43%
3.61%
Earnings forecast
--
$0.24
Profitability
RNLSY
Sector
Profitability FY 2024
$12.7B
$456.7M
Return on invested capital
0.77%
4.58%
Return on assets
0.6%
2.72%
Return on equity
4.5%
6.7%
Earnings Date
Last Earnings Date
Feb
20
Next Earnings Date
Jul
31
Estimated Next Earnings Date
May
22
Balance Sheet
RNLSY
Sector
Total cash
$23.4B
$139.6M
Short term investments
$554.6M
$46.8M
Total assets
$134.6B
$1.4B
Long term debt
--
$128.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
